Informations techniques
Exploitant
Laboratoires PROSTRAKAN PHARMA
Présentation
DROLEPTAN 2,5 mg/ 1ml, solution injectable (IV) B/10 - CIP 561 122-8
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
JVwLQm6m7hm8yyjW